Skip to main content

Viatris, Inc. (VTRS)

NASDAQ: VTRS · IEX Real-Time Price · USD
13.94 -0.07 (-0.50%)
Oct 22, 2021 4:00 PM EDT - Market closed
Market Cap16.84B
Revenue (ttm)15.60B
Net Income (ttm)-2.05B
Shares Out1.21B
EPS (ttm)-2.16
PE Ration/a
Forward PE3.58
Dividend$0.22 (1.58%)
Ex-Dividend DateAug 23, 2021
Volume3,719,546
Open14.01
Previous Close14.01
Day's Range13.91 - 14.10
52-Week Range12.75 - 18.59
Beta1.46
AnalystsBuy
Price Target20.15 (+44.5%)
Est. Earnings DateNov 8, 2021

About VTRS

Viatris Inc., a healthcare company, develops, licenses, manufactures, markets, and distributes brand and generic drugs, complex generics, biosimilars, and active pharmaceutical ingredients (APIs) worldwide. The company operates through Developed Markets, Greater China, JANZ, and Emerging Markets segments. It offers drugs in various therapeutic areas, including infectious diseases and non-communicable diseases; HIV/AIDS; and oncology, immunology, endocrinology, ophthalmology, and dermatology, as well as antibacterial, central nervous system agen...

IndustryPharmaceuticals
Employees40,000
Stock ExchangeNASDAQ
Ticker SymbolVTRS
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 19 analysts, the average rating for Viatris stock is "Buy." The 12-month stock price forecast is 20.15, which is an increase of 44.55% from the latest price.

Price Target
$20.15
(44.55% upside)
Analyst Consensus: Buy

News

Wall Street Analysts See a 33% Upside in Viatris (VTRS): Can the Stock Really Move This High?

The mean of analysts' price targets for Viatris (VTRS) points to a 33.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts i...

13 hours ago - Zacks Investment Research

3 Dirt-Cheap Stocks Wall Street Thinks Will Soar 43% to 80%

Analysts are bullish about these bargains.

Other symbols:JAZZNVAX
19 hours ago - The Motley Fool

Viatris' First-Ever Interchangeable Insulin Biosimilar Preferred on Express Scripts' Largest Formulary

PITTSBURGH, Oct. 20, 2021 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) is proud to confirm that Express Scripts, a leading pharmacy benefit management organization, will list Viatris' interchangeable bio...

2 days ago - PRNewsWire

Cigna's pharmacy benefit unit to prefer cheaper insulin drug from Viatris

Cigna Corp's pharmacy benefit unit said on Wednesday it will prefer Viatris Inc and Biocon Biologics Ltd's insulin drug Semglee, a cheaper alternative to Sanofi SA's Lantus, on the list of medicines it ...

Other symbols:CI
2 days ago - Reuters

3 No-Brainer Biotech Stocks to Buy Right Now

Regeneron Pharmaceuticals, Vertex Pharmaceuticals, and Viatris should have plenty of room to run.

Other symbols:REGNVRTX
6 days ago - The Motley Fool

Is Viatris a good buy opportunity at the current share price?

Wall Street's three main indexes are advancing this Thursday; treasury yields are dropping, and buying sentiment remains high. Viatris Inc. (NASDAQ: VTRS) shares are still not able to stabilize above $1...

1 week ago - Invezz

4 Unstoppable Stocks to Buy If There's a Stock Market Crash

Crashes and corrections are the perfect opportunity to buy great companies at a discount.

Other symbols:SETCNNF
1 week ago - The Motley Fool

Viatris Inc. to Release Third Quarter 2021 Financial Results on Nov. 8, 2021

PITTSBURGH, Oct. 13, 2021 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) plans to release its third quarter 2021 financial results on Monday, Nov. 8, before the open of the U.S. financial markets. Chief Ex...

1 week ago - PRNewsWire

Viatris Named Fifth on Fortune's Change the World List

PITTSBURGH, Oct. 11, 2021 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a new kind of global healthcare company, today announced that Fortune has named the company fifth out of 53 on its Change the World...

1 week ago - PRNewsWire

2 Ultra-Cheap Stocks Trading Below Their Book Values

And these stocks also pay relatively high dividends.

Other symbols:KHC
2 weeks ago - The Motley Fool

Viatris Is Cheap

Viatris Inc. ( VTRS , Financial) was formed by the combination of generic pharmaceutical company Mylan and Upjohn, Pfizer Inc.'s ( PFE , Financial) off-patent segment. Though the Mylan part of the combi...

2 weeks ago - GuruFocus

The Best Dividend Stocks to Buy for the Fourth Quarter (and Beyond)

Whether you're a growth or value investor, there's an income stock for all preferences.

Other symbols:AVGOV
2 weeks ago - The Motley Fool

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Viatris Inc. and Encourages Inv...

LOS ANGELES--(BUSINESS WIRE)---- $VTRS #MYL--INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Viatris Inc.

3 weeks ago - Business Wire

5 Ultra-Popular Stocks With 120% to 190% Upside, According to Wall Street

Analysts' loftiest price targets portend significant upside for these widely owned (and followed) stocks.

Other symbols:BNGOCGCNIOSKLZ
3 weeks ago - The Motley Fool

Is It Time to Buy the S&P 500's 3 Worst-Performing Stocks?

Viatris, Las Vegas Sands, and Take-Two Interactive are trailing the market in 2021. You should consider buying two of them but stay away from the third.

Other symbols:LVSTTWO
3 weeks ago - The Motley Fool

3 Top Biotech Stocks to Buy for the Long Haul

Each of these three stocks offers yields that more than double the S&P 500's current yield.

Other symbols:AMGNAZN
3 weeks ago - The Motley Fool

Is Now the Time to Ditch Pharma Stocks?

With drug pricing reform on the horizon, investors may want to analyze their allocation.

1 month ago - The Motley Fool

7 Spinoff Stocks to Buy That Are Set to Outperform Their Parents

Companies often spin off pieces of their businesses into independent entities. Many of these spinoff stocks to buy have benefited from the distance.

Other symbols:AIRCCGNTGXOIFFVMEO
1 month ago - InvestorPlace

3 Dividend Stocks With 133% to 155% Upside, According to Wall Street

Wall Street's loftiest price targets suggest these income stocks could more than double.

Other symbols:KGCMU
1 month ago - The Motley Fool

Why Wall Street Thinks This Dirt Cheap Value Stock Could Soar

It's kind of a boring stock. But analysts think that it could deliver not-so-boring growth.

1 month ago - The Motley Fool

Why Is Viatris (VTRS) Down 3% Since Last Earnings Report?

Viatris (VTRS) reported earnings 30 days ago. What's next for the stock?

1 month ago - Zacks Investment Research

3 Dividend Stocks to Buy If You're Worried About the Stock Market

You can invest in these solid stocks with a peace of mind.

Other symbols:DEADUK
1 month ago - The Motley Fool

4 Market-Topping Dividend Stocks That Can Double Your Money by 2026

With yields ranging from 2.3% to 10.1%, these income stocks can quickly build wealth for investors.

Other symbols:AGNCIIPRNLY
1 month ago - The Motley Fool

Got $5,000? These 2 Dividend Stocks Are Dirt Cheap Buys

And their yields are both over 3%.

Other symbols:SU
1 month ago - The Motley Fool

Viatris Inc. to Participate in BofA Global Healthcare Conference

PITTSBURGH, Aug. 30, 2021 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced the company will take part in a virtual fireside chat at the BofA Global Healthcare Conference on Wednesday, Septemb...

1 month ago - PRNewsWire